Skip to main content
SpringerLink
Log in

Erster Attachment-Inhibitor in der Phase II

Neue Substanzklasse für die HIV-Therapie

  • PHARMAFORUM
  • Published:
MMW - Fortschritte der Medizin Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Satellitensymposium „Mit Erfahrung in die Zukunft“ im Rahmen der 15. Münchner AIDS- und Hepatitis-Tage; München, März 2014 (Veranstalter: Bristol-Myers Squibb)

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Andrea Warpakowski

Authors
  1. Andrea Warpakowski
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Warpakowski, A. Erster Attachment-Inhibitor in der Phase II. MMW - Fortschritte der Medizin 156 (Suppl 24), 60 (2014). https://doi.org/10.1007/s15006-014-3121-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-014-3121-8

Search

Navigation